Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful
tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring …

Simple Summary Despite the increased use of neoadjuvant chemotherapy in the early
setting of breast cancer, there is a clinical need for predictive markers of response in daily …

Simple Summary Immune Checkpoint Inhibitors (ICIs) have demonstrated clinical efficacy in
Microsatellite Instability High Colorectal Cancer (MSI-H CRC). However, in Microsatellite …

The war against cancer traces back to the signature event half-a-century ago when the US
National Cancer Act was signed into law. The cancer crusade costs trillions with …

The tremendous advances in electrochemical biosensing that have occurred recently,
highlighting as never before the versatility and adaptability of the resulting biotools, together …

Liquid biopsies have emerged as a promising tool for the detection of metastases as well as
local and regional recurrence in lung cancer. Liquid biopsy tests involve analyzing a …

Circulating tumor DNA (ctDNA) has emerged as a promising biomarker of minimal residual
disease (MRD) in solid tumors. There is increasing evidence to suggest that the detection of …

Ovarian cancer is the deadliest gynecological cancer. 70% of the cases are diagnosed at
late stages with already developed metastases due to the absence of easily noticeable …

Abstract Background Circulating tumor DNA (ctDNA) is increasingly used as a biomarker for
metastatic rectal cancer and has recently shown promising results in the early detection of …

Cancer is becoming a global pandemic, and its occurrence is increasing rapidly, putting a
strain on people's families, health systems, and finances, in addition to their physical …